Pharmacokinetic and Pharmacodynamic Properties of Single- and Multiple-Dose of Dapagliflozin, a Selective Inhibitor of SGLT2, in Healthy Chinese Subjects
Yang Li(University of Cambridge), David W. Boulton(AstraZeneca (Poland)), Sreeneeranj Kasichayanula(Gilead Sciences (United States)), Anh Thi Ngoc Bui(Bristol-Myers Squibb (United States)), Frank LaCreta(Fox Chase Cancer Center), Haiyan Li(Peking University), Hongmei Li(Guizhou Provincial People's Hospital), Steven C. Griffen(Io Therapeutics (United States)), Xiaoni Liu(Bristol-Myers Squibb (Germany)), Ming Chang
Cited by 43
Related Papers
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
|Journal of Clinical Investigation|2009|1.7k
Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation
|Journal of the American College of Cardiology|2019|494
Increased Toll-Like Receptor (TLR) 2 and TLR4 Expression in Monocytes from Patients with Type 1 Diabetes: Further Evidence of a Proinflammatory State
|The Journal of Clinical Endocrinology & Metabolism|2007|373